IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CMND

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021
Cash & Equivalents9.263.504.475.788.315.435.250.18--4.60
Total Current Assets11.023.825.026.418.695.795.840.43----
Total Non-current Assets*0.120.150.160.170.150.160.150.53----
Total Assets11.143.975.186.588.855.95--------
Total Current Liabilities2.912.902.883.724.204.97--------
Total Non-current Liabilities*0.000.000.000.010.004.97--------
Total Liabilities2.912.902.883.734.204.97--------
Retained Earnings(31.73)(27.19)(25.88)(25.09)(21.04)(18.77)(14.12)(13.85)----
Total Stockholder Equity8.241.072.302.854.650.983.34(1.51)1.334.80
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q2 2022Q1 2022
Research & Development0.640.720.450.460.350.320.230.260.320.791.160.42
Selling, General & Admin3.020.680.861.031.130.981.160.841.341.681.061.66
Total Operating Expenses3.661.411.311.501.471.301.381.101.662.472.222.08
Operating Income----------------(1.66)(2.47)(2.22)(2.08)
Pretax Income(3.85)(1.31)(0.76)(1.03)(2.05)(0.87)(1.17)(0.58)(2.07)(1.90)(2.33)(2.09)
Tax Provision0.000.010.020.040.040.040.20(0.01)0.010.00----
Net Income(3.85)(3.17)(1.86)(1.07)(2.09)(0.91)(1.37)(0.58)(2.08)(2.46)--(2.09)
Basic EPS(3.32)(0.25)(0.16)(0.24)(0.59)(0.28)(0.90)(2.43)(0.55)(1.07)(1.78)(1.67)
Diluted EPS(3.32)(0.25)(0.16)(0.24)(0.59)(0.28)(0.77)(2.43)(0.55)(1.07)(1.78)(1.67)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q1 2024Q1 2023Q1 2022
Operating Cash Flow(2.08)(3.45)(2.36)(1.27)(1.46)(4.12)(1.79)
Investing Cash Flow--(0.02)(0.13)0.07------
Financing Cash Flow7.420.380.390.405.328.45--
← Scroll for more columns →